Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects Publications, Year: 2021, Highlighted ArticlesScienceSitesJuly 9, 2021 Facebook0 Twitter LinkedIn0 Reddit Tumblr 0 Likes